InvestorsHub Logo
Followers 34
Posts 4311
Boards Moderated 0
Alias Born 07/16/2014

Re: LakeshoreLeo1953 post# 248616

Thursday, 04/30/2020 9:17:08 AM

Thursday, April 30, 2020 9:17:08 AM

Post# of 462057

It is a difficult world we live in when a discussion
of Anavex proves impossible due to a basic misunderstanding of
serum concentration and dosage,




That confusion is intentional imho. How could management have explained why they did not include the “effective” doses from the 2a in the 2b/3 trial. That “T” thing would have cropped it’s ugly head.


Does this quote from Anavex’s presentation clear things up?




“97% Consistency: MMSE, ADCS-ADL and EEG/ERPs: Identified relations show that high dose (concentration) is linked to improved response and low dose (concentration) to poor response

The doses they were comparing were 10,20,30,40 and 50 mgs.



Just because they are now calling 10 low and 20 high doesn’t explain a darn thing imho.




Page 22



https://www.anavex.com/wp-content/uploads/2018/05/Anavex-ANAVEX2-73-CTAD-Phase-2a-November-2017.pdf

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News